Clinical Trial Report

By No Comments
ADVANCED STAGE MELANOMAImmunotherapy Study for Patients With Stage IV Melanoma Sponsored by NewLink Genetics Corporation, the main objective of this study is to determine the safety and clinical response rate…
Read More

Pipeline Previews

By No Comments
KYTHERA Biopharmaceuticals Announces FDA Approval of KYBELLA™ KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) announced today that the U.S. Food and Drug Administration (FDA) has approved KYBELLA™, also known as ATX-101, “for improvement in…
Read More